Originally published by our sister publication General Surgery News
Nicholas J. Skertich, MD, MS
LONG BEACH, Calif.—Weight-loss medications such as glucagon-like peptide-1 receptor agonists (GLP-1s) are occasionally maligned by surgeons, but they can have a role in the bariatric surgery process, according to Nicholas J. Skertich, MD, MS. Although he made it clear that metabolic bariatric surgery is the most effective stand-alone treatment for obesity, he believes GLP-1s